Market Research Logo

Preimplantation Genetic Diagnosis (PGD) Market by End-users and Geography - Global Forecast and Analysis 2019-2023

Preimplantation Genetic Diagnosis (PGD) Market by End-users and Geography - Global Forecast and Analysis 2019-2023

Global Preimplantation Genetic Diagnosis (PGD) Market: About this Market

Preimplantation genetic diagnosis (PGD) is a genetic testing procedure that is performed before the implantation of oocytes or embryos for the identification of genetic abnormalities, such as aneuploidy, single-gene disorders, and X- and Y-linked disorders. It is commonly performed when one or both expecting parents have such abnormalities and are at a high risk of passing them to their offspring. Technavio’s preimplantation genetic diagnosis market analysis considers sales of devices to fertility clinics and maternity centers, hospitals and diagnostic laboratories, and research institutions. Our analysis also considers the sales of preimplantation genetic diagnosis in Asia, Europe, North America, and ROW. In 2018, the fertility clinics and maternity centers segment held the highest market share, which is expected to remain prevalent over the forecast period. Factors such as the rising demand for PGD testing to increase the chances of successful IVF pregnancies in couples with previous unexplainable IVF failures will significantly help the segment in maintaining its leading market position. Also, our global preimplantation genetic diagnosis report has observed market growth factors such as increasing demand for early diagnosis of genetic disorders, rising adoption of IVF treatments, and decreasing cost of genetic sequencing and IVF treatments. However, challenges such as the presence of stringent regulations related to genetic diagnosis, ethical concerns associated with genetic testing of embryos, and concerns about safety and privacy of genetic data may hamper the growth of the preimplantation genetic diagnosis industry over the forecast period.

Global Preimplantation Genetic Diagnosis Market: Overview

Increasing demand for early diagnosis of genetic disorders

With advances in the diagnostic and treatment procedures in the healthcare sector, the demand for early diagnostic techniques is rising. The need for early diagnosis, during genetic IVF techniques and other artificial insemination procedures, has become crucial owing to the rising need to prevent health conditions in new-borns. Furthermore, governments and non-profit organizations are organizing awareness programs about the benefits of early diagnosis of genetic disorders to promote the wellbeing of women and children. Vendors are capitalizing on these factors and are increasingly offering PGD devices. As a result, the global preimplantation genetic diagnosis market will record a CAGR of over 10% during 2019-2023.

Growing demand for non-invasive biopsy procedures in PGD

Vendors are focusing on further innovation on PGD procedures to increase their sales volume an cater to the rising demand for improved techniques. This gave rise to non-invasive biopsy procedures, which offer several benefits over conventional biopsy procedures and avoid risks associated with the removal of cells from embryos. Therefore, the demand for non-invasive biopsy procedures in PGD is growing, which is one of the key preimplantation genetic diagnosis market trends. The trend is expected to have a positive impact on the overall preimplantation genetic diagnosis market growth during the forecast period.

For the detailed list of factors that will drive the global preimplantation genetic diagnosis market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of a few major players, the global preimplantation genetic diagnosis market is moderately concentrated. Technavio’s robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of few leading vendors such as Genea Ltd., Igenomix Sl, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, Natera Inc., Oxford Gene Technology Group, PerkinElmer Inc., Quest Diagnostics Inc., and Thermo Fisher Scientific Inc.

Also, the preimplantation genetic diagnosis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies in strategizing and leveraging on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
      • Table Product overview
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global healthcare market
      • Table Segments of global healthcare market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by end-user
    • Table End-user - Market share 2018-2023 (%)
    • Comparison by end-user
      • Table Comparison by end-user
    • Fertility clinics and maternity centers - Market size and forecast 2018-2023
      • Table Fertility clinics and maternity centers - Market size and forecast 2018-2023 ($ millions)
      • Table Fertility clinics and maternity centers - Year-over-year growth 2019-2023 (%)
    • Hospitals and diagnostic laboratories - Market size and forecast 2018-2023
      • Table Hospitals and diagnostic laboratories - Market size and forecast 2018-2023 ($ millions)
      • Table Hospitals and diagnostic laboratories - Year-over-year growth 2019-2023 (%)
    • Research institutes - Market size and forecast 2018-2023
      • Table Research institutes - Market size and forecast 2018-2023 ($ millions)
      • Table Research institutes - Year-over-year growth 2019-2023 (%)
    • Market opportunity by end-user
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market Trends
    • Advances in genetic sequencing technologies
    • Rising adoption of online testing kits and services
    • Growing demand for non-invasive biopsy procedures in PGD
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Genea Ltd.
      • Table Genea Ltd. - Vendor overview
      • Table Genea Ltd. - Business segments
      • Table Genea Ltd. - Organizational developments
      • Table Genea Ltd. - Key offerings
    • Igenomix Sl
      • Table Igenomix Sl - Vendor overview
      • Table Igenomix Sl - Business segments
      • Table Igenomix Sl - Organizational developments
      • Table Igenomix Sl - Key offerings
    • Illumina Inc.
      • Table Illumina Inc. - Vendor overview
      • Table Illumina Inc. - Business segments
      • Table Illumina Inc. - Organizational developments
      • Table Illumina Inc. - Geographic focus
      • Table Illumina Inc. - Segment focus
      • Table Illumina Inc. - Key offerings
    • Invitae Corp.
      • Table Invitae Corp. - Vendor overview
      • Table Invitae Corp. - Business segments
      • Table Invitae Corp. - Organizational developments
      • Table Invitae Corp. - Geographic focus
      • Table Invitae Corp. - Key offerings
    • Laboratory Corp. of America Holdings
      • Table Laboratory Corp. of America Holdings - Vendor overview
      • Table Laboratory Corp. of America Holdings - Business segments
      • Table Laboratory Corp. of America Holdings - Organizational developments
      • Table Laboratory Corp. of America Holdings - Geographic focus
      • Table Laboratory Corp. of America Holdings - Segment focus
      • Table Laboratory Corp. of America Holdings - Key offerings
    • Natera Inc.
      • Table Natera Inc. - Vendor overview
      • Table Natera Inc. - Business segments
      • Table Natera Inc. - Organizational developments
      • Table Natera Inc. - Geographic focus
      • Table Natera Inc. - Key offerings
    • Oxford Gene Technology Group
      • Table Oxford Gene Technology Group - Vendor overview
      • Table Oxford Gene Technology Group - Business segments
      • Table Oxford Gene Technology Group - Organizational developments
      • Table Oxford Gene Technology Group - Key offerings
    • PerkinElmer Inc.
      • Table PerkinElmer Inc. - Vendor overview
      • Table PerkinElmer Inc. - Business segments
      • Table PerkinElmer Inc. - Organizational developments
      • Table PerkinElmer Inc. - Geographic focus
      • Table PerkinElmer Inc. - Segment focus
      • Table PerkinElmer Inc. - Key offerings
    • Quest Diagnostics Inc.
      • Table Quest Diagnostics Inc. - Vendor overview
      • Table Quest Diagnostics Inc. - Business segments
      • Table Quest Diagnostics Inc. - Organizational developments
      • Table Quest Diagnostics Inc. - Segment focus
      • Table Quest Diagnostics Inc. - Key offerings
    • Thermo Fisher Scientific Inc.
      • Table Thermo Fisher Scientific Inc. - Vendor overview
      • Table Thermo Fisher Scientific Inc. - Business segments
      • Table Thermo Fisher Scientific Inc. - Organizational developments
      • Table Thermo Fisher Scientific Inc. - Geographic focus
      • Table Thermo Fisher Scientific Inc. - Segment focus
      • Table Thermo Fisher Scientific Inc. - Key offerings
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report